Find us on
 
 

ADMETECH FOUNDATION: OVERVIEW

MISSION
The AdMeTech Foundation is a 501(c)(3) nonprofit organization based in Boston, MA. Our mission is to end the prostate cancer crisis.

VISION
AdMeTech provides international leadership and conducts ground-breaking programs in research and education for facilitated development of accurate diagnostic tools for early detection and minimally-invasive treatment of prostate cancer to:

  • Save lives, improve quality of life in millions of men, and reduce billions of dollars in health care costs, and
  • End the era of blind prostate cancer care and create the future of image-guided, least invasive, and precisely targeted diagnosis and treatment that can be performed in outpatient clinics with minimal patient discomfort, complications, and costs.

APPROACH
To achieve these goals, AdMeTech has undertaken a public awareness campaign to recognize the prostate cancer crisis as a national priority and to increase public and private funding for research. As the result of this campaign, US Congress introduced historic legislation including the Prostate Research Imaging and Men’s Education (PRIME) Act and House Resolution 353. The PRIME Act, which calls for government funding of $650 million over 5 years for research and education to advance prostate cancer diagnostics is currently under consideration by the US Senate. House Resolution 353 was passed unanimously in June 2008 and expressed, “...the sense of the US House of Representatives that there should be increased support for research and development of advanced imaging technologies for prostate cancer detection and treatment.

Massachusetts General Court and Boston City Council both issued resolutions recognizing the AdMeTech Foundation for its efforts in research and awareness to improve early detection and treatment of prostate cancer.

Read Massachusetts General Court Resolution
Read Boston City Council Resolution

 
IN THE HEADLINES
AWARD WINNING IMAGING RESEARCH ADDRESSES THE FUNDAMENTAL CHALLENGE IN PROSTATE CANCER CARE AS FRAMED BY CONGRESSIONAL HEARING ON MAY 4,2010
  Press Coverage
  Lauterbur Award
US CONGRESS HOLDS HISTORIC HEARING ON PROSTATE CANCER, ADMETECH WILL TESTIFY.
  Press Release
  Hearing Announcement
  AdMeTech Testifies
  NBC Coverage
  C-Span Coverage
  USA today
REP. CUMMINGS INTRODUCES THE $650 MILLION PRIME ACT IN RESPONSE TO THE CONGRESSIONAL HEARING.
  Press Coverage
US CONGRESS APPROVES $1.6 MILLION FOR ADMETECH'S RESEARCH PROGRAMS
  Coverage
SENATOR BOXER URGES US CONGRESS TO SUPPORT THE PROSTATE CANCER IMAGING AND MEN’S EDUCATION (PRIME) ACT
  Congressional Record
  Letter to US Senate
  Prime Act
CUMMINGS, WAXMAN AND OTHER MEMBERS OF US CONGRESS URGE NCI / NIH TO FUND PROSTATE IMAGING
  Letter
  Press Release
US CONGRESS PASSES HISTORIC RESOLUTION CALLING FOR INCREASED NATIONAL INVESTMENT IN PROSTATE CANCER IMAGING
  Press Release
  Resolution
  Coverage by Roll Call
June 12, 2008
  Rep. Elijah Cummings Successfully Introduces House Resolution 353 (Video)
ADMETECH HOLDS PROSTATE CANCER AWARENESS DAY AT MASSACHUSETTS STATE HOUSE
  Program
  Press Release
  Coverage
  Photos
MASSACHUSETTS STATE HOUSE RECOGNIZES ADMETECH FOR PROSTATE CANCER AWARENESS DAY
  Resolution
BOSTON CITY COUNCIL RECOGNIZES ADMETECH FOR ITS ONGOING EFFORTS IN AWARENESS AND RESEARCH
  Resolution
  Photos
PRESIDENT OBAMA DECLARES SEPTEMBER, 2009 AS NATIONAL PROSTATE CANCER AWARENESS MONTH
  Press Release
WALL STREET JOURNAL COVERS PROSTATE CANCER IMAGING AND ITS ROLE IN:
  Accurate diagnosis - Part I
March 31, 2009
  Treatment - Part II
April 7, 2009
  Watchful waiting - Part III
April 17, 2009
NBC COVERS THE NEED TO CREATE LIFE-SAVING PROSTATE CANCER DIAGNOSTICS
  Coverage
FOX BUSINESS NEWS COVERS "THE MANOGRAM PROJECT" & THE NEED FOR NATIONAL INVESTMENT IN PROSTATE CANCER RESEARCH
  Coverage
ADMETECH’S CONSENSUS CONFERENCE OF JANUARY, 2009 BRINGS TOGETHER WORLD EXPERTS
  Agenda
  Faculty Members
  Consensus Statement
  Signed Letter to NIH and NCI
  Coverage by Reuters
Additional News Items
News Archive